Leitlinien der Deutschen Urologen zur Diagnostik des BPH- Syndroms

Urologe - Ausgabe A

Volumn 38, Issue 3, 1999, Pages 297-303

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GERMANY; HUMAN; MALE; PRACTICE GUIDELINE; PROSTATE HYPERTROPHY;

GERMANY; HUMANS; MALE; PROSTATIC HYPERPLASIA;

EID: 0009821669     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001200050285     Document Type: Article

References (66)

1. Griffiths K, Coffey D, Cockett A, di Sant' Agnese A, Ichikawa T, Krieg M, Lee C, McKeehan W, Schalken J, Sciarra F, Steiner G, Sugimura Y, Yamanaka H. The regulation of prostatic growth, in: Cockett ATK, Khoury S, Aso Y, Chatelain C, Denis L, Griffiths K, Murphy G (eds): The 3rd international consultation on benign prostatic hyerplasia (BPH), Scientific Communication International Ltd., Monaco, 1996.73-121
2. Krieg M, Tunn S. Androgens and human benign prostatic hyperplasia (BPH), in: Nieschlag EH, Behre HM (eds.): Testosterone: Action, deficiency, substitution. Springer, New York, Berlin, Heidelberg, 1990.219-44
3. Krieg M, Weisser H, Tunn S. Potential activities of androgen metabolizing enzymes in human prostate. Journal of Steroid Biochemistry and Molecular Biology. 1995; 53: 395-400
4. Walsh PC. Human benign prostatic hyperplasia: etiological considerations, in:Kimball FA et al. (eds.) New approaches to the study of benign prostatic hyperplasia. Alan R Liss, New York, 1984.1-25
5. Aarnink RG, de la Rosette JJMCH, Debruyne FMJ, Wijkstra H.Formula-derived prostatevolume determination. European Urology1996;29: 399-402
6. Aarnink RG, de la Rosette JJMCH, et.al. Reproducibility of prostate volume measurements from transrectal ultrasonography by an automated and a manual technique. British Journal of Urology. 1996; 78: 219-23
7. Abrams P. Objective evaluation of bladder outlet obstruction. British Journal of Urology. 1995; 76: 11-5
8. Ameda K, Koyanagi T, Nantani M, Taniguchi K, Matsuno T. The relevance of preoperative cystometrography in patients with benign prostatic hyperplasia: correlating the findings with clinical features and outcome after prostatectomy. Journal of Urology. 1994; 152: 443-7
9. Anderson JR, Strickland D, Corbin D, Byrnes JA, Zweiback E. Age-specific reference ranges for serum prostate-specific antigen. Urology. 1995; 46: 54-7
10. Anyanwu SNC. Is routine urography necessary in all patients undergoing suprapubic transvesical prostatectomy? East African Medical Journal. 1995; 72, 2: 78
11. Bosch JLHR. Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World Journal of Urology. 1995; 13: 17-20
12. Bosch JLHR, Hop WCJ, Kirkels WJ, Schröder FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British Journal of Urology. 1995; 75: 622-30
13. Chandiramani VA, Palace J, Fowler CJ. How to recognize patients with parkinsonism who should not have urological surgery. British Journal of Urology. 1997; 80: 100-4
14. Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. British Journal of Urology. 1994; 73: 117-21
15. Comiter CV, Sullivan MP, Schacterle RS, Cohen LH, Valla SV. Urodynamic risk factors for renal dysfunction in men with obstructive and nonobstructive voiding dysfunction. Journal of Urology. 1997; 158: 181-5
16. De la Rosette JJMCH, Witjes WPJ, Debruyne FMJ, Kerstein PL, Wijkstra H. Improved reliability of uroflowmetry investigations: results of a portable home-based uroflowmetry study. British Journal of Urology. 1996; 78: 385-90
17. Diokno AC. Editorial: the impact of technological and scientific advances in understanding, evaluating and managing bladder and outlet obstruction. Journal of Urology. 1996; 155: 527-8
18. Dörsam J, Kälble T, Riedasch G, Staehler G. Wertigkeit der bildgebenden Diagnostik bei benigner Prostatahyperplasie und beim Prostatakarzinom. Radiologe. 1994; 34: 101-8
19. Du Beau CE, Sullivan MP, Cravalho E, Resnick NM, Yalla SV. Correlation between micturitional urethral pressure profile and pressure-flow criteria in bladder outlet obstruction. Journal of Urology. 1995; 154: 498-503
20. Dunsmuir WD, Feneley M, Corry DA, Bryan CJ, Kirby RS. The day-to-day variation (test-retest reliability) of residual urine measurement. British Journal of Urology. 1996; 77, 2: 192-3
21. El Din K, Koch WFRM, de Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH. The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia. European Urology. 1996; 30: 409-13
22. El Din KE, Kiemeney LALM, de Wildt MJAM, Debruyne FMJ, de La Rosette JJMCH. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score. Urology. 1996; 48: 393-7
23. Fall M, Geirsson G, Lindstrom S. Towards a new classification of overactive bladders. Neurourology and Urodynamics. 1995; 14, 6: 635-46
24. Feneley MR, Dunsmuir WD, Pearce J, Kirby RS. Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia. Urology. 1996; 47, 5: 658-63
25. Gerber GS. The role of urodynamic study in the evaluation and management of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 1996; 48: 668-75
26. Gleason DM, Bottaccini MR, McRae LP. Noninvasive urodynamics: A study of male voiding dysfunction. Neurourology and Urodynamics. 1997; 16: 93-100
27. Goessl C, Knispel HH, Miller K, Klan R. Is routine excretory urography necessary at first diagnosis of bladder cancer? Journal of Urology. 1997; 157: 480-1
28. Goldenberg S, Gleave M, Bruchovsky N, Rennie P. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis - Editorial Comment. Journal of Urology. 1997; 157: 2267
29. Griffiths D, Harrison G, Moore K, McCracken P. Longterm changes in urodynamics studies of voiding in the elderly. Urological Research. 1994; 22: 235-8
30. Griffiths D. Basics of pressure-flow studies. World Journal of Urology. 1995; 13: 30-3
31. Griffiths D, Höfner K, van Mastrigt R, Rollema HJ, Spangberg A, Gleason D. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourology and Urodynamics. 1997; 16: 1-18
32. Hadorn DC, Baker D, Hodges JS, Hicks N. Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology. 1996; 49: 749-54
33. Hall MC, Roehrborn CG, McConnell JD. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia? Seminars in Urologic Oncology. 1996; 14: 122-33
34. Harzmann R, Weckermann D. Diagnostik und Therapie des Prostataadenoms - Bewährtes und Neues. Medizinische Welt. 1995; 46: 454-7
35. Hasegawa Y, Sakamoto N, Gotoh K. Relationship of ultrasonic and histologic findings in benign prostatic hyperplasia. Prostate. 1996; 28, 2: 111-6
36. Höfner K, Kramer EJL, Tan HK, Krah H, Jonas U. CHESS classification of bladder-outflow obstruction. A consequence in the discussion of current concepts. World Journal of Urology. 1995; 13: 59-64
37. Jacobsen SJ. Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men? Urology. 1995; 45: 64-9
38. Janknegt RA, Roehrborn CG. The role of the general practitioner in the diagnosis and treatment of benign prostatic hyperplasia (BPH). Progress in Clinical and Biological Research. 1994; 386: 313-29
39. Javle P, Jenkins SA, West C, Parsons KE. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy. Journal of Urology. 1996; 156: 1014-9
40. Jensen KME, Jorgensen JB, Morgensen P. Long-term predictive role of urodynamics: an 8-year follow-up of prostatic surgery for lower urinary tract symptoms. British Journal of Urology. 1996; 78, 27: 213-8
41. Jonas U, Kramer G, Hofner K. The principles and clinical application of advanced urodynamic analysis for BPH. Progress in Clinical and Biological Research. Kurth K, Newling DWW. Benign prostatic hyperplasia. New York, 1994; 386: 141-56
42. Jonas U, Höfner K. Symptom scores, watchful waiting and prostate specific antigen levels in benign prostatic hyperplasia - Editorial. Journal of Urology. 1996; 156: 1040-1
43. Jorgensen JG, Jensen KME. Uroflowmetry. Urologic Clinics of North America. 1996; 23, 2: 237-42
44. Kaplan SA, Te AE. Uroflowmetry and urodynamics. Urologic Clinics of North America. 1995; 22: 309-20
45. Kaplan SA, Reis RB. Significant correlation of the American Urological Association symptom score and a novel urodynamic parameter: Detrusor contraction duration. Journal of Urology. 1996; 156: 1668-72
46. Koch WFRM, Ezzeldin K, de Wildt MJAM, Debruyne FMJ, de la Rosette JJMCH. The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia. Journal of Urology. 1996; 155: 186-9
47. Lim CS, Abrams P. The Abrams-Griffiths Nomogram. World Journal of Urology. 1995; 13: 34-9
48. Madersbacher S, Klingler HC, Diavan B, Stulnig T, Schatzl G, Schmidbauer CP, Marberger M. Is obstruction predictable by clinical evaluation in patients with lower urinary tract symptoms? British Journal of Urology. 1997; 80: 72-7
49. Madsen FA, Bruskewitz RC. Cystoscopy in the evaluation of benign prostatic hyperplasia. World Journal of Urology. 1995; 13: 14-6
50. McConnell JD. Why pressure-flow studies should be optional and not mandatory studies for evaluating men with benign prostatic hyperplasia. Urology. 1994; 44: 156-8
51. McGuire E. Editorial comment - Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourology and Urodynamics. 1996; 15: 470-1
52. Nathan MS, Seenivasagam K, Mei Q, Wickham JEA, Miller RA. Transrectal ultrasonography: why are estimates of prostate volume and dimension so inaccurate? British Journal of Urology. 1996; 77: 401-7
53. Netto NR, D'Ancona CAL, Lopes de Lima M. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia. Journal of Urology. 1996; 155: 200-2
54. Oesterling JE, Girman CJ, Panser LA, Chute CG, Barrett DM, Guess HA, Lieber MM. Correlation between urinary flow rate, voided volume, and patient age in a community-based population. Progress in Clinical and Biological Research. Kurth K, Newling DWW. Benign prostatic hyperplasia. New York, 1994; 386: 125-39
55. Reynard JM, Peters TJ, Lim C, Abrams P. The value of multiple free-flow studies in men with lower urinary tract symptoms. British Journal of Urology. 1996; 77: 813-8
56. Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, Jacobsen SJ, Garraway WM, Lieber MM. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 1997; 49: 548-57
57. Rosier PFWM, de la Rosette JJMCH. Is there a correlation between prostata size and bladder-outlet obstruction? World Journal of Urology. 1995; 13: 9-13
58. Ruud Bosch JLH. Postvoid residual urine in the evaluation of men with benign prostatic hyperplasia. World Journal of Urology. 1995; 13: 17-20
59. Schacterle RS, Sullivan MP, Yalla SV. Reply - Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourologyand Urodynamics. 1996; 15: 471-2
60. Schäfer W, de la Rosette JJMCH, Höfner K, Kinn AC, Walter S, Abrams P. The ICS BPH study: pressure-flow studies, quality control and initial analysis. Neurourologyand Urodynamics. 1994; 13: 491-2
61. Schleicher C, Neumann R, Kaiser WA, Stein G. Zur Indikation der intravenösen Urographie. Medizinische Klinik. 1997; 92: 79-82
62. Sullivan MP, Comiter CV, Yalla SV. Micturitional urethral pressure profilometry. Urologic Clinics of North America. 1996; 23, 2: 263-78
63. Ukimura O, Kojima M, Inui E, Ochiai A, Hata Y, Watanabe M, Saitoh M, Watanabe H. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography. Journal of Urology. 1996; 156: 1673-8
64. van de Beek C, Stoevelaar HJ, McDonnell J, Nijs HGT, Casparie AF, Janknegt RA. Interpretation of uroflowmetry curves by urologists. Journal of Urology. 1997; 157: 164-8
65. van Venrooij GEPM, Boon TA. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis. Journal of Urology. 1996; 155, 6: 2014-8
66. Witjes WPJ, de Wildt MJAM, Rosier PFWM, Caris CTM, Debruyne FMJ, de la Rosette JJMCH. Variability of clinical and pressure-flow study variables after 6 months of watchful waiting in patients with lower urinary tract symptoms and benign prostatic enlargement. Journal of Urology. 1996; 156: 1026-33